美国社区起病脓毒症血流感染的流行病学、耐药谱与结局
该回顾性队列研究利用2016至2020年Premier医疗数据库201家美国医院的数据,纳入147061例社区起病脓毒症成人患者,采用美国疾病控制中心成人脓毒症事件监测标准定义脓毒症。血培养阳性脓毒症21167例(14%),非血培养阳性脓毒症20326例(14%);血培养阳性者中革兰阴性杆菌占55%、革兰阳性球菌占47%,耐甲氧西林金黄色葡萄球菌(MRSA)占11%、耐头孢曲松肠杆菌目/超广谱β-内酰胺酶占7%、耐碳青霉烯肠杆菌目占1.3%。粗院内死亡率在培养阴性脓毒症为17%、非血培养阳性脓毒症为13%、血培养阳性脓毒症为17%。多水平logistic回归显示,与培养阴性脓毒症相比,血培养阳性脓毒症(aOR 0.89;95%CI 0.85-0.94)和非血培养阳性脓毒症(aOR 0.82;95%CI 0.78-0.87)与更低的院内死亡风险相关;不动杆菌属、铜绿假单胞菌、甲氧西林敏感金黄色葡萄球菌和MRSA与更高的院内死亡率相关,而大肠埃希菌、克雷伯菌属、变形杆菌属和链球菌属与更低的院内死亡率相关。
要点
- 社区起病脓毒症成人患者中,血培养阳性脓毒症占14%(21167/147061),非血培养阳性脓毒症占14%(20326/147061)。
- 血培养阳性者中革兰阴性杆菌占55%、革兰阳性球菌占47%;MRSA占11%,耐头孢曲松肠杆菌目/ESBL占7%,耐碳青霉烯肠杆菌目占1.3%。
- 粗院内死亡率:培养阴性脓毒症17%,非血培养阳性脓毒症13%,血培养阳性脓毒症17%。
- 校正后,与培养阴性脓毒症相比,血培养阳性脓毒症院内死亡aOR 0.89(95%CI 0.85-0.94),非血培养阳性脓毒症aOR 0.82(95%CI 0.78-0.87)。
- 不动杆菌属、铜绿假单胞菌、甲氧西林敏感金黄色葡萄球菌和MRSA与更高院内死亡率相关;大肠埃希菌、克雷伯菌属、变形杆菌属和链球菌属与更低院内死亡率相关。
适用人群与场景
- 2016至2020年美国201家医院收治的成人社区起病脓毒症患者,且入院2天内采集血培养。
- 脓毒症定义采用美国疾病控制中心成人脓毒症事件监测标准。
诊断标准与关键阈值
- 脓毒症诊断标准:美国疾病控制中心成人脓毒症事件监测标准。
研究设计与关键结果
- 研究类型:回顾性队列研究;数据来源:2016至2020年Premier医疗数据库,201家美国医院;样本量:147061例社区起病脓毒症成人患者。
- 血培养阳性脓毒症21167例(14%),非血培养阳性脓毒症20326例(14%)。
- 血培养阳性者中,革兰阴性杆菌占55%,革兰阳性球菌占47%;MRSA占11%,耐头孢曲松肠杆菌目/超广谱β-内酰胺酶占7%,耐碳青霉烯肠杆菌目占1.3%。
- 粗院内死亡率:培养阴性脓毒症17%,非血培养阳性脓毒症13%,血培养阳性脓毒症17%。
- 多水平logistic回归:与培养阴性脓毒症相比,血培养阳性脓毒症院内死亡aOR 0.89(95%CI 0.85-0.94),非血培养阳性脓毒症aOR 0.82(95%CI 0.78-0.87)。
- 与更高院内死亡率相关的病原体:不动杆菌属、铜绿假单胞菌、甲氧西林敏感金黄色葡萄球菌、MRSA。
- 与更低院内死亡率相关的病原体:大肠埃希菌、克雷伯菌属、变形杆菌属、链球菌属。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在社区起病脓毒症成人患者中,血培养阳性者约占14%,且耐药菌(MRSA 11%、耐头孢曲松肠杆菌目/ESBL 7%、耐碳青霉烯肠杆菌目1.3%)不常见。
- 与培养阴性脓毒症相比,血培养阳性及非血培养阳性脓毒症均与更低的院内死亡风险相关,提示血培养结果阳性本身不提示更差预后,需结合病原体种类判断。
- 不动杆菌属、铜绿假单胞菌、甲氧西林敏感金黄色葡萄球菌和MRSA感染与更高院内死亡率相关,而大肠埃希菌、克雷伯菌属、变形杆菌属和链球菌属感染与更低院内死亡率相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To describe frequency of positive blood cultures, patterns of pathogens' characteristics and their resistance profile in patients with blood cultures drawn due to a presumed diagnosis of community-onset sepsis, and to examine the association between blood culture-positive pathogens and hospital mortality.
DESIGN: Retrospective cohort study.
SETTING: Two hundred one U.S. hospitals from 2016 to 2020 using the Premier Healthcare Database.
SUBJECTS: Adult patients presenting with community-onset sepsis who had blood cultures collected within 2 days of hospital admission. We defined sepsis using the U.S. Centers for Disease Control Adult Sepsis Event Surveillance criteria.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We identified 147,061 patients with community-onset sepsis. The number of blood culture-positive sepsis episodes was 21,167 (14%) and the number of nonblood culture-positive sepsis episodes was 20,326 (14%). Among patients with blood culture-positive sepsis, Gram-negative rods were isolated in 55% of patients, Gram-positive cocci were isolated in 47%. Of those, methicillin-resistant Staphylococcus aureus (MRSA) was 11%, ceftriaxone-resistant Enterobacterales /extended-spectrum β-lactamase was 7%, and carbapenem-resistant Enterobacterales was 1.3%. The crude in-hospital mortality was 17% for culture-negative sepsis, 13% for nonblood culture-positive sepsis, and 17% for blood culture-positive sepsis. In multilevel logistic regression models, compared with culture-negative sepsis, blood culture-positive sepsis (adjusted odds ratio [aOR], 0.89; 95% CI, 0.85-0.94) and nonblood culture-positive sepsis (aOR, 0.82; 95% CI, 0.78-0.87) were associated with lower odds of in-hospital mortality. Acinetobacter species, Pseudomonas aeruginosa , methicillin-sensitive Staphylococcus aureus , and MRSA were associated with higher in-hospital mortality, whereas Escherichia coli , Klebsiella species, Proteus species, and Streptococcus species were associated with lower in-hospital mortality.
CONCLUSIONS: In patients hospitalized with community-onset sepsis, the prevalence of blood culture-positive sepsis was 14%. Among positive blood culture sepsis resistant organisms were infrequent. Compared with culture-negative sepsis, blood culture-positive sepsis and nonblood culture-positive sepsis were associated with lower in-hospital mortality.
参考来源
- Ohnuma T, Chihara S, Costin B, et al. Epidemiology, Resistance Profiles, and Outcomes of Bloodstream Infections in Community-Onset Sepsis in the United States. Crit Care Med. 2023. PMID: 37276351. doi:10.1097/CCM.0000000000005870
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。